CG Oncology CEO bought more than $2.3 million in shares
Arthur Kuan, CEO of CG Oncology, bought 30,000 common shares of the company on November 18, 2026 at $78.88 per share, for a total of $2,366,400, according to a Form 4 filed with the SEC. After the transaction, he directly held 228,916 shares.
In 20 seconds
- Kuan bought 30,000 common shares of CG Oncology.
- The price was $78.88 per share, for a total of $2,366,400.
- After the purchase, the CEO directly held 228,916 shares.
IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.